<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Bomfim CCB</submitter><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><funding>Division of Cancer Prevention, National Cancer Institute</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><pubmed_abstract>Irg1 is an enzyme that generates itaconate, a metabolite that plays a key role in the regulation of inflammatory responses. Previous studies have implicated Irg1 as an important mediator in preventing excessive inflammation and tissue damage in &lt;i>Mycobacterium tuberculosis&lt;/i> (&lt;i>Mtb&lt;/i>) infection. Here, we investigated the pattern recognition receptors and signaling pathways by which &lt;i>Mtb&lt;/i> triggers Irg1 gene expression by comparing the responses of control and genetically deficient BMDMs. Using this approach, we demonstrated partial roles for TLR-2 (but not TLR-4 or -9), MyD88 and NFκB signaling in Irg1 induction by &lt;i>Mtb&lt;/i> bacilli. In addition, drug inhibition studies revealed major requirements for phagocytosis and endosomal acidification in Irg1 expression triggered by &lt;i>Mt</pubmed_abstract><journal>Frontiers in cellular and infection microbiology</journal><pagination>862582</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9109611</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>Mycobacterium tuberculosis&lt;/i> Induces &lt;i>Irg1&lt;/i> in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.</pubmed_title><pmcid>PMC9109611</pmcid><pubmed_authors>Chari R</pubmed_authors><pubmed_authors>Sher A</pubmed_authors><pubmed_authors>Correa AAS</pubmed_authors><pubmed_authors>D'Imperio Lima MR</pubmed_authors><pubmed_authors>Mittereder L</pubmed_authors><pubmed_authors>Amaral EP</pubmed_authors><pubmed_authors>McVicar DW</pubmed_authors><pubmed_authors>Namasivayam S</pubmed_authors><pubmed_authors>Fisher L</pubmed_authors><pubmed_authors>Weiss JM</pubmed_authors><pubmed_authors>Costa DL</pubmed_authors><pubmed_authors>Swamydas M</pubmed_authors><pubmed_authors>Moayeri M</pubmed_authors><pubmed_authors>McCann K</pubmed_authors><pubmed_authors>Bomfim CCB</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Mycobacterium tuberculosis&lt;/i> Induces &lt;i>Irg1&lt;/i> in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.</name><description>Irg1 is an enzyme that generates itaconate, a metabolite that plays a key role in the regulation of inflammatory responses. Previous studies have implicated Irg1 as an important mediator in preventing excessive inflammation and tissue damage in &lt;i>Mycobacterium tuberculosis&lt;/i> (&lt;i>Mtb&lt;/i>) infection. Here, we investigated the pattern recognition receptors and signaling pathways by which &lt;i>Mtb&lt;/i> triggers Irg1 gene expression by comparing the responses of control and genetically deficient BMDMs. Using this approach, we demonstrated partial roles for TLR-2 (but not TLR-4 or -9), MyD88 and NFκB signaling in Irg1 induction by &lt;i>Mtb&lt;/i> bacilli. In addition, drug inhibition studies revealed major requirements for phagocytosis and endosomal acidification in Irg1 expression triggered by &lt;i>Mt</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T09:31:21.316Z</modification><creation>2024-12-03T23:30:58.229Z</creation></dates><accession>S-EPMC9109611</accession><cross_references><pubmed>35586249</pubmed><doi>10.3389/fcimb.2022.862582</doi></cross_references></HashMap>